共 32 条
[1]
Semisyntheseetstructureproposeeduplatelet activatingfactor:PAF acether,unalkyletheranaloguedelalysophophatidylchloine. BenvenisteJ,TenceM,VareeneP ,etal. CRAcadSci . 1979
[2]
RES[P]. 澳大利亚专利:AU5679373A,1974-12-12
[3]
Confirmatoryplatelet activatingfactorreceptorantagonisttrialinpatientswithseveregram negativebacterialsepsis :aphaseⅢ ,randomized ,double blind ,placebo controlled ,multicentertrial.BN 5 2 0 2 1Sep sisInvestigatorGroup. DhainautJF,TenaillonA,HemmerM ,etal. Critical Care Medicine . 1998
[4]
Platelet-activating factor antagonists. Negro Alvarez JM,Miralles Lopez JC,Ortiz Martinez JL, et al. Allergologia et Immunopathologia . 1997
[5]
Conformationandactivityoftetrahydrofuranlignansandanaloguesasspecificplateletactivat ingfactorantagonists. BiftuT,GambleNF,DoebberT ,etal. Journal of Medicinal Chemistry . 1986
[6]
ComparisonofthereversedpassiveArthusandlocalShwartzmanreactionsofrabbitskin :ef fectsofthelong actingPAFantagonistUK 74,5 0 5. NormanKE,WilliamsTJ,RossiAG. BrJPhar macol . 1997
[7]
IncreasedplasmalevelsofplateletactivatingfactorandlowserumPAFacetylhydro lase(PAFAH)activetyinadultpatientswithbronchialasthma. TsukiokaK,MatsuzakiM,NakamataM ,etal. Arerygi . 1993
[8]
E 5 880. DrugFut . 1992
[9]
Formationof 1 alkyl 2 acetyl sn glycerolsviathedenovobiosyntheticpathwayforplatelet activat ingfactor. LeeTC,MaloneB,SnyderF. Journal of Biochemistry . 1988
[10]
BallenolideG ,anaturalPAF re ceptorantagonist. LiaoCH,KoFN,WuTS ,etal. JPharmPharmacol . 1997